Savvy Updates, 3/10/25: Dexcom’s FTC Warning Letter over Deficiencies, Double Diabetes, Mounjaro vs. Ozempic, Sleep & Glycemic Variability, Pathways to T1D Pharma Therapies, diaTribe Kidney /Heart /Metabolism Webinar, Smartphones & Brain Activity Impact, Hibiscus Health “Selfies” Detect D, FTC on PBMs System of “Disgusting” Higher Prices

Savvy Updates, 3/10/25: Dexcom’s FTC Warning Letter over Deficiencies, Double Diabetes, Mounjaro vs. Ozempic, Sleep & Glycemic Variability, Pathways to T1D Pharma Therapies, diaTribe Kidney /Heart /Metabolism Webinar, Smartphones & Brain Activity Impact, Hibiscus Health “Selfies” Detect D, FTC on PBMs System of “Disgusting” Higher Prices

Mar 10, 2025 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Dexcom’s FTC Warning Letter over Deficiencies Double Diabetes:  Silent Threat Hiding in Type 1 Patients Mounjaro vs. Ozempic: Which One Is Right for You? Sleep Duration & Timing and Impact on...
Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

Nov 4, 2024 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Omnipod 5 & the iPhone App Abbott CGM Sensors OK in MRI FDA Rejects Sotagliflozin for T1D Chinese Stem Cell-Based Therapies Semaglutide for Knee Osteoarthritis Pain Beta Bionics Launches iLet with Abbott...
Savvy Updates: 10/28/24: Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

Savvy Updates: 10/28/24: Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

Oct 28, 2024 | Diabetes Business, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  New Insulin to Prevent Sudden BG Drops Luna Diabetes Clinical Trial for AID Closed-Loop for MDI Levicure’s Triple-Combo Oral Therapy to Restore Insulin Production GLP-1, SGLT2 Drug Scripts on the Rise...
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Sep 14, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates

Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
Savvy Updates 6/3/24: Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

Savvy Updates 6/3/24: Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

Jun 3, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates

The Modular Medical MODD1 insulin pump. What do we know? by Tim Street for Diabettech.com, 31 May 2024. Modular Medical recently submitted their new pump system to the FDA for approval. It’s described as: “Effortless Insulin Delivery Made Possible.”...
Skip to content